Suppr超能文献

慢性肾小球肾炎中的尿海藻糖酶活性

Urinary trehalase activity in chronic glomerulonephritis.

作者信息

Niwa T, Katsuzaki T, Yazawa T, Tatemichi N, Emoto Y, Miyazaki T, Maeda K

机构信息

Department of Internal Medicine, Nagoya University Branch Hospital, Japan.

出版信息

Nephron. 1993;63(4):423-8. doi: 10.1159/000187246.

Abstract

To determine the diagnostic role of urinary trehalase in chronic glomerular disease, urinary trehalase activity and other urinary markers such as N-acetyl-beta-D-glucosaminidase (NAG), alanine aminopeptidase (AAP), alkaline phosphatase (ALP), gamma-glutamyltranspeptidase (gamma-GTP), lactate dehydrogenase (LDH), lysozyme and beta 2-microglobulin (BMG) were measured in patients with chronic glomerulonephritis, nephrotic syndrome and chronic renal failure. Urinary trehalase activity was significantly increased in chronic glomerular disease, especially nephrotic syndrome, as compared with that in the healthy subjects. The highest incidence of elevated excretion was observed for trehalase with 52% in chronic glomerular disease, followed by NAG. Urinary trehalase activities in the patients were significantly correlated with the urinary levels of protein, NAG and AAP and total score of tubular damage, but not correlated with urinary levels of BMG or lysozyme. In patients with chronic glomerulonephritis and nephrotic syndrome, there was no significant difference in urinary trehalase activities between with and without hematuria. These results indicate that in some patients with chronic glomerular disease, there is tubular involvement as substantiated by elevation of the other urinary enzymes and BMG. Urinary trehalase is elevated more often in these types of disease than other markers of tubular damage.

摘要

为了确定尿海藻糖酶在慢性肾小球疾病中的诊断作用,我们检测了慢性肾小球肾炎、肾病综合征和慢性肾衰竭患者的尿海藻糖酶活性以及其他尿标志物,如N - 乙酰 - β - D - 氨基葡萄糖苷酶(NAG)、丙氨酸氨基肽酶(AAP)、碱性磷酸酶(ALP)、γ - 谷氨酰转肽酶(γ - GTP)、乳酸脱氢酶(LDH)、溶菌酶和β2 - 微球蛋白(BMG)。与健康受试者相比,慢性肾小球疾病,尤其是肾病综合征患者的尿海藻糖酶活性显著升高。海藻糖酶排泄升高的发生率最高,在慢性肾小球疾病中为52%,其次是NAG。患者的尿海藻糖酶活性与尿蛋白水平、NAG和AAP水平以及肾小管损伤总分显著相关,但与BMG或溶菌酶的尿水平无关。在慢性肾小球肾炎和肾病综合征患者中,有无血尿的患者尿海藻糖酶活性无显著差异。这些结果表明,在一些慢性肾小球疾病患者中,存在肾小管受累,这由其他尿酶和BMG的升高所证实。在这些类型的疾病中,尿海藻糖酶升高的频率比其他肾小管损伤标志物更高。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验